Loading...
The US FDA has approved Lilly's bowel disease drug for treatment in adults. Prime Medicine's prime editing technology successfully corrected mutations in monkeys, passing a major test. Researchers are exploring new methods to deliver healthy genes, including better viruses and tools to repair damaged genes. DNA writing technologies are advancing towards synthetic genomes. A gene-editing trial for an HIV cure yielded uncertain results. The US FDA is shifting COVID antivirals to the commercial market. COVID-19 treatments are expected to have high price tags. The US FDA has cleared the first China-developed cancer drug similar to Merck's Keytruda. A scientist is developing custom gene-editing tools. Verve Therapeutics has been cleared by the FDA to begin a gene-editing treatment study for high cholesterol.
The FDA cleared Verve Therapeutics to begin U.S. study of gene-editing treatment for high cholesterol. https://t.co/M0wXbIIAep
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions https://t.co/d4TfytfkQn
The US FDA has cleared the first China-developed cancer drug similar to Merck’s blockbuster therapy Keytruda - a rare success among Chinese biotechnology firms seeking to break into the world’s most lucrative market https://t.co/gHOkWvCLLZ
The US FDA has cleared the first China-developed cancer drug similar to Merck’s blockbuster therapy Keytruda - a rare success among Chinese biotechnology firms seeking to break into the world’s most lucrative market https://t.co/WWZOByMbQb
COVID-19 treatments to enter the market with a hefty price tag https://t.co/So61izitPn
US shifting COVID antivirals to commercial market on Nov. 1 https://t.co/6ujXeEf83f https://t.co/XAwKZifYPe
Gene-Editing Trial on Three Individuals for HIV Cure Yields Uncertain Result https://t.co/ZAUVNYJ3or
DNA writing technologies moving toward synthetic genomes https://t.co/xbhahiLAsv
Today, researchers are seeking new ways to deliver healthy genes. Some are developing better viruses or nonviral ferries, while others are using new tools to repair or replace damaged genes in place. https://t.co/kCr20lz32M
Prime Medicine says its refinement of CRISPR passed the major test of correcting a genetic flaw in monkeys. https://t.co/qJ74jmCzkW
In major test for prime editing, Prime Medicine $PRME scientists successfully correct mutations in monkeys https://t.co/kDKZFYYAVC A DEEP dive into the new data, and how it compares to Flagship's Tessera, from @Jasonmmast
Lilly's bowel disease drug gets US FDA nod for treatment in adults https://t.co/ddzrBbrHws https://t.co/mj31O876WF